Agile Therapeutics Total Liabilities 2013-2023 | AGRX
Agile Therapeutics total liabilities from 2013 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
Agile Therapeutics Annual Total Liabilities
(Millions of US $) |
| 2023 |
$27 |
| 2022 |
$20 |
| 2021 |
$35 |
| 2020 |
$24 |
| 2019 |
$4 |
| 2018 |
$2 |
| 2017 |
$14 |
| 2016 |
$22 |
| 2015 |
$21 |
| 2014 |
$19 |
| 2013 |
$86 |
| 2012 |
$86 |
Agile Therapeutics Quarterly Total Liabilities
(Millions of US $) |
| 2023-12-31 |
$27 |
| 2023-09-30 |
$23 |
| 2023-06-30 |
$25 |
| 2023-03-31 |
$23 |
| 2022-12-31 |
$20 |
| 2022-09-30 |
$12 |
| 2022-06-30 |
$29 |
| 2022-03-31 |
$27 |
| 2021-12-31 |
$35 |
| 2021-09-30 |
$26 |
| 2021-06-30 |
$28 |
| 2021-03-31 |
$24 |
| 2020-12-31 |
$24 |
| 2020-09-30 |
$23 |
| 2020-06-30 |
$22 |
| 2020-03-31 |
$18 |
| 2019-12-31 |
$4 |
| 2019-09-30 |
$2 |
| 2019-06-30 |
$2 |
| 2019-03-31 |
$1 |
| 2018-12-31 |
$2 |
| 2018-09-30 |
$8 |
| 2018-06-30 |
$10 |
| 2018-03-31 |
$12 |
| 2017-12-31 |
$14 |
| 2017-09-30 |
$17 |
| 2017-06-30 |
$18 |
| 2017-03-31 |
$21 |
| 2016-12-31 |
$22 |
| 2016-09-30 |
$20 |
| 2016-06-30 |
$20 |
| 2016-03-31 |
$20 |
| 2015-12-31 |
$21 |
| 2015-09-30 |
$22 |
| 2015-06-30 |
$20 |
| 2015-03-31 |
$20 |
| 2014-12-31 |
$19 |
| 2014-09-30 |
$18 |
| 2014-06-30 |
$18 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
|
| 2013-09-30 |
$0 |
| 2013-06-30 |
$0 |
| 2012-12-31 |
$86 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.003B |
$0.020B |
|
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
|
